Changes in Regional and Global Cardiac Contractility After Stimulation in Scar Zone with the NOGA System
SCARPACE
1 other identifier
interventional
12
1 country
1
Brief Summary
Despite a decrease in voltage amplitude in post-infarction scar areas, greater voltage amplitudes are sometimes observed at the time of local extrasystoles mechanically induced by catheters. However, no study has investigated whether these electrical changes are associated with mechanical changes in local contractility. However, the voltage is closely correlated to the local contractile function as evidenced by the use of the NOGA system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedStudy Start
First participant enrolled
February 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedOctober 23, 2024
October 1, 2024
3.9 years
February 4, 2021
October 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evolution of LLS (linear local shortening) via the NOGATM system in percentage
Study the change in percentage of LLS during stimulation in a post-infarction scar zone identified by voltage mapping of the left ventricle with the NOGA system, compared to LLS in the same zone measured in atrial stimulation
1month
Secondary Outcomes (3)
Evolution of global systolic function: left ventricular ejection fraction
1month
Evolution of the global systolic function: integral time velocity under aortic Translation results Evolution of the global systolic function: integral time velocity under aortic
1month
Evolution of the global systolic function: strain longitudinal global
1month
Study Arms (1)
NOGA TM probe
EXPERIMENTALInterventions
Each subject will be his own witness since the linear local shortening (LLS) will be measured successively in all patients before, then after stimulation of the scar zone (comparison of LLS measured in sinus rhythm then during stimulation in the scar zone for each patient. Each subject being his own witness and the two recordings being made a few minutes apart, during the same procedure.
Eligibility Criteria
You may qualify if:
- \- Patients who should undergo ventricular tachycardia (VT) ablation after a myocardial infarction according to current recommendations, namely: patients with ischemic heart disease (ICD) and with episodes of sustained ventricular tachycardia responsible for internal electric shocks by the implantable automatic defibrillator (ICD) (grade IB recommendation)
- patients with an MIC and an ICD, presenting a first episode of sustained ventricular tachycardia (grade IIa, B recommendation)
- Affiliated with a social protection scheme
- Having signed an informed consent
You may not qualify if:
- Contraindication or non-indication for ventricular tachycardia ablation
- Women who are pregnant or of childbearing age and without contraception, breastfeeding women
- Patients without ischemic heart disease
- Patients under guardianship, curatorship or legal protection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ROLLIN Anne
Toulouse, CHU de Toulouse, 31059, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne ROLLIN, MD
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2021
First Posted
February 17, 2021
Study Start
February 23, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
October 23, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share